Target intelligence / Profile preview

Constitutive decay element-containing messenger RNA (CDE-containing mRNA)

Target
CDE-containing mRNA
Molecular classification
Other
01

Overview

Messenger RNAs containing a constitutive decay element are transcripts that include specific sequence motifs—termed constitutive decay elements (CDEs)—typically found in the 3′ untranslated region (3′ UTR). These motifs promote rapid and constitutive mRNA degradation, independently of the classical AU-rich elements (AREs)[1][2][3][4][5]. The best-studied example is TNF-α mRNA, in which the CDE, distinct from AREs, ensures that the message is short-lived, avoiding excessive protein (e.g., cytokine) production. The principal molecular mechanism involves recognition of the stem-loop CDE motif by the ROQ domain of Roquin family RNA-binding proteins; this interaction targets the mRNA for decay and is important in the post-transcriptional regulation of inflammation and immune responses[1][2][3][4]. Clarification: This is not a protein, enzyme, transporter, or receptor, but rather a class of mRNA transcripts defined by the presence of a sequence element involved in post-transcriptional regulation[1][2][3]. As such, it is not a direct therapeutic target itself, but elements of the CDE or the proteins interacting with it—most notably Roquin—are sometimes considered therapeutic targets in inflammation or autoimmune disease research[1]. The entry is thus not appropriate as a conventional drug target entry, but is biologically significant as a cis-regulatory RNA motif.

Other names
Constitutive decay element mRNACDE-mRNAMessenger RNA with constitutive decay element
02

Biological functions

mRNA stability regulationmRNA degradation
03

Disease associations

CancerInflammationOther

Beyond the preview

Go deeper on Constitutive decay element-containing messenger RNA (CDE-containing mRNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Constitutive decay element-containing messenger RNA (CDE-containing mRNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call